U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
SUCLA2-related mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria (SUCLA2-related mtDNA depletion syndrome) is characterized by onset of the following features in infancy: developmental delay, hypotonia, dystonia, muscular atrophy, sensorineural hearing impairment, growth failure, and feeding difficulties. Other less frequent features include choreoathetosis, muscle weakness, recurrent vomiting, ptosis, and kyphoscoliosis. The median survival is age 20 years; approximately 30% of affected individuals succumb during childhood.

Genes See tests for all associated and related genes

  • Also known as: A-BETA, A-SCS, LINC00444, MTDPS5, SCS-betaA, SUCLA2
    Summary: succinate-CoA ligase ADP-forming subunit beta

Clinical features

Help

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.